Application of novel non-invasive ophthalmic imaging to visualize peripapillary wrinkles, retinal folds and peripapillary hyperreflective ovoid mass-like structures associated with elevated intracranial pressure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 2,53 MB, PDF-dokument

  • Michaela Graven-Nielsen
  • Alfredo Dubra
  • Robert L. Dodd
  • Hamann, Steffen
  • Heather E. Moss
Background: Elevated intracranial pressure (ICP) is a serious and potentially life-threatening condition, for which clinically useful non-invasive measures have been elusive, in some cases due to their inadequate sensitivity and specificity. Our aim was to evaluate novel non-invasive ophthalmic imaging of selected pathological features seen in elevated ICP, namely peripapillary hyperreflective ovoid mass-like structures (PHOMS), peripapillary wrinkles (PPW) and retinal folds (RF) as potential biomarkers of elevated ICP.

Methods: This single-center pilot study included subjects with untreated or incompletely treated high ICP. The retinas of these subjects were evaluated with averaged en-face optical coherence tomography (OCT), OCT retinal cross-sections (OCT B-scans), adaptive optics scanning light ophthalmoscopy (AOSLO), and fundus photos.

Results: Seven subjects were included in the study. 6 subjects with high ICP (5 idiopathic intracranial hypertension, 1 medication induced, 30.8 ± 8.6 years, 75% female, 5 with papilledema) and 1 control (20–25 years) were included. PHOMS, PPW and RF were present in all subjects with papilledema, but neither in the high ICP subject without papilledema nor in the control subject. Averaged en-face OCT scans and AOSLO were more sensitive for PPW and RF than OCT B-scans and commercial fundus photos.

Conclusion: PPW, RF and PHOMS volume have potential as non-invasive biomarkers of ICP. Novel imaging modalities may improve sensitivity. However, lack of automated image acquisition and processing limits current widespread adoption in clinical settings. Further research is needed to validate these structures as biomarkers for elevated ICP and improve clinical utility.
OriginalsprogEngelsk
Artikelnummer1383210
TidsskriftFrontiers in Neurology
Vol/bind15
Antal sider15
ISSN1664-2295
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The study was funded by NIH P30 026877 and the Unrestricted Grant from Research to Prevent Blindness to the Stanford Department of Ophthalmology. Research Gift from Pierce the Darkness (Carver, MN, USA).

Publisher Copyright:
Copyright © 2024 Graven-Nielsen, Dubra, Dodd, Hamann and Moss.

ID: 398557718